Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection-Authors' reply.
Saved in:
| Title: | Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection-Authors' reply. |
|---|---|
| Authors: | Hsu YC; Center for Liver Diseases and Department of Medical Research, E-Da Hospital, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan., Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.; Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California, USA., Wu CY; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Oct; Vol. 58 (7), pp. 733-734. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.17681 |
